Genome engineered, preclinical models of serrated colorectal cancer to fast-track a high sensitivity, early detection test

点击翻译按钮获取中文摘要

1 in 12 Australians will develop colorectal cancer. Here we use information about changes to the genetic (inherited) material of these cancers to develop new, complex models of this disease. This teaches us about what those changes do, and highlights important targets for future drug therapies. We are also developing a better test to detect hidden pre-cancers that are not well detected by our current population screening strategy, to help reduce deaths from this disease.